NO830900L - Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.

Info

Publication number
NO830900L
NO830900L NO830900A NO830900A NO830900L NO 830900 L NO830900 L NO 830900L NO 830900 A NO830900 A NO 830900A NO 830900 A NO830900 A NO 830900A NO 830900 L NO830900 L NO 830900L
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutic active
tricyclic derivatives
active tricyclic
Prior art date
Application number
NO830900A
Other languages
English (en)
Other versions
NO162385B (no
Inventor
James Frederick Eggler
Michael Ross Johnson
Lawrence Sherman Melvin Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO830900L publication Critical patent/NO830900L/no
Priority to NO880538A priority Critical patent/NO163188C/no
Publication of NO162385B publication Critical patent/NO162385B/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/33—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups or etherified hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C07C33/20—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
NO830900A 1982-03-16 1983-03-15 Heksanhydropyrrolo-(1, 2-a)kinolin-og heksanhydro-1h-pyrido-(1,2-a)kinolin-forbindelser. NO162385B (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO880538A NO163188C (no) 1982-03-16 1988-02-08 Analogifremgangsm te for fremstilling av terapeutisk aktive heksahydropyrollo-(1,2-a)kinolin-, heksahydro-1h-pyrido-(1,2-a)kinolin-eller oktahydrofenantrenforbindelser.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/358,569 US4476131A (en) 1982-03-16 1982-03-16 Substituted hexahydropyrrolo[1,2-a]-quinolines, hexahydro-1H-pyrido[1,2-a]-q

Publications (2)

Publication Number Publication Date
NO830900L true NO830900L (no) 1983-09-19
NO162385B NO162385B (no) 1989-09-11

Family

ID=23410189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830900A NO162385B (no) 1982-03-16 1983-03-15 Heksanhydropyrrolo-(1, 2-a)kinolin-og heksanhydro-1h-pyrido-(1,2-a)kinolin-forbindelser.

Country Status (27)

Country Link
US (1) US4476131A (no)
EP (1) EP0090516B1 (no)
JP (2) JPS58170724A (no)
KR (2) KR870001126B1 (no)
AR (1) AR240936A1 (no)
AT (1) ATE35544T1 (no)
AU (1) AU543215B2 (no)
CA (1) CA1254567A (no)
CS (1) CS249126B2 (no)
DD (2) DD219765A5 (no)
DE (1) DE3377280D1 (no)
DK (1) DK85183A (no)
ES (2) ES8503510A1 (no)
FI (1) FI76334C (no)
GR (1) GR77127B (no)
HU (1) HU189906B (no)
IE (1) IE54897B1 (no)
IL (1) IL68131A (no)
NO (1) NO162385B (no)
NZ (1) NZ203577A (no)
PH (1) PH19998A (no)
PL (2) PL141501B1 (no)
PT (1) PT76390B (no)
RO (2) RO88221B (no)
SU (1) SU1355130A3 (no)
YU (2) YU44736B (no)
ZA (1) ZA831781B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576964A (en) * 1982-03-16 1986-03-18 Pfizer Inc. Substituted hexahydrobenzo[e]indene and octahydrophenanthrene CNS agents and pharmaceutical compositions thereof
US4670562A (en) * 1985-03-13 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydropyrrolo[1,2-b]isoquinolinedione oximes
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
CA2187257A1 (en) * 1995-10-12 1997-04-13 Enrique Luis Michelotti Aryl-substituted cycloalkanes and cycloalkenes and herbicidal use thereof
CN1075498C (zh) * 1997-05-08 2001-11-28 车庆明 一种查尔酮c甙和它的用途
US6316734B1 (en) 2000-03-07 2001-11-13 3M Innovative Properties Company Flexible circuits with static discharge protection and process for manufacture
ITGE20080051A1 (it) 2008-06-04 2009-12-05 Matteucci Francesco Metodo per la realizzazione di cavi diamantati rinforzati per il taglio di strutture e materiali in acciaio,calcestruzzo,acciaio e calcestruzzo,materiali litoidi o simili e cavo diamantato rinforzato ottenuto mediante tale metodo.
CN112778241A (zh) * 2021-03-09 2021-05-11 中国科学院兰州化学物理研究所 一种四氢呋喃乙酸及其酯类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3045020A (en) * 1962-07-17 x xcooa
FR1490023A (fr) * 1965-08-17 1967-07-28 Sandoz Sa Dérivés de l'isoquinoléine et leur préparation
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
US4188495A (en) * 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor

Also Published As

Publication number Publication date
AR240936A2 (es) 1991-03-27
HUT34146A (en) 1985-02-28
IL68131A0 (en) 1983-06-15
DK85183A (da) 1983-09-17
ATE35544T1 (de) 1988-07-15
ES520630A0 (es) 1985-03-01
AU1244883A (en) 1983-09-22
HU189906B (en) 1986-08-28
PL245846A1 (en) 1984-08-27
AU543215B2 (en) 1985-04-04
DE3377280D1 (en) 1988-08-11
US4476131A (en) 1984-10-09
PL141501B1 (en) 1987-07-31
JPS63183542A (ja) 1988-07-28
JPS58170724A (ja) 1983-10-07
DK85183D0 (da) 1983-02-24
AR240936A1 (es) 1991-03-27
PT76390B (en) 1986-02-03
EP0090516B1 (en) 1988-07-06
FI76334B (fi) 1988-06-30
PL240989A1 (en) 1984-06-18
KR880002412B1 (ko) 1988-11-08
PT76390A (en) 1983-04-01
YU60683A (en) 1986-04-30
ES8503510A1 (es) 1985-03-01
EP0090516A1 (en) 1983-10-05
PL141640B1 (en) 1987-08-31
RO85382B (ro) 1984-11-30
RO85382A (ro) 1984-11-25
ES527075A0 (es) 1985-04-16
YU44899B (en) 1991-04-30
YU175785A (en) 1986-08-31
DD210270A5 (de) 1984-06-06
IE830559L (en) 1983-09-16
FI830857A0 (fi) 1983-03-15
SU1355130A3 (ru) 1987-11-23
CA1254567A (en) 1989-05-23
NZ203577A (en) 1985-09-13
ZA831781B (en) 1983-11-30
CS249126B2 (en) 1987-03-12
KR870001126B1 (ko) 1987-06-09
PH19998A (en) 1986-08-28
IE54897B1 (en) 1990-03-14
ES8504097A1 (es) 1985-04-16
YU44736B (en) 1991-02-28
IL68131A (en) 1986-07-31
KR840004111A (ko) 1984-10-06
DD219765A5 (de) 1985-03-13
FI76334C (fi) 1988-10-10
GR77127B (no) 1984-09-07
JPH0260653B2 (no) 1990-12-17
NO162385B (no) 1989-09-11
FI830857L (fi) 1983-09-17
KR880006969A (ko) 1988-07-25
RO88221A (ro) 1985-12-30
RO88221B (ro) 1986-01-02

Similar Documents

Publication Publication Date Title
NO832431L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165148C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av tricykliske aminosyrer.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO893616L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser.
NO831610L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater.
NO884174D0 (no) Framgangsmaate for fremstilling av terapeutisk aktive tricykliske amidinoderivater.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO830900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO832329L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tricykliske forbindelser.
NO813263L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater
NO163529C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte azabicykloalkaner.
NO162617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater.
NO160001C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater.